McIlwraith G R, Kidner P H, Oram S
Br Heart J. 1980 Sep;44(3):335-41. doi: 10.1136/hrt.44.3.335.
Nifedipine is a new antianginal drug, the calcium-antagonistic inhibitory action on excitation-contraction coupling apparently being so pronounced that, in therapeutic dosage, all other pharmacological properties are negligible. Its effect on exercise tolerance in angina was assessed by an exercise study involving 14 patients: single-stage exercise tests were chosen and the advantages of this are given. Our results suggest that the onset of action occurs after about 20 minutes, reaches a peak of activity at approximately one-half to two hours, and some effect may still be present at three hours. There was a significant improvement in exercise times with a mean rise of 50 per cent over placebo.
硝苯地平是一种新型抗心绞痛药物,其对兴奋 - 收缩偶联的钙拮抗抑制作用非常显著,以至于在治疗剂量下,所有其他药理特性均可忽略不计。通过一项涉及14名患者的运动研究评估了其对心绞痛患者运动耐力的影响:选择了单阶段运动试验并说明了其优点。我们的结果表明,起效时间约为20分钟后,在大约半小时至两小时达到活性峰值,三小时时可能仍有一些作用。运动时间有显著改善,平均比安慰剂组提高了50%。